Natural History of the HBsAg Carrier
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.
Anderson M, Harrison T, Alexander G, Zuckerman A, Murray-Lyon I Gut. 1987; 28(5):619-22.
PMID: 3297940 PMC: 1432882. DOI: 10.1136/gut.28.5.619.
An acupuncture-associated outbreak of hepatitis B in Jerusalem.
Slater P, Leventhal A, Zahger D, Bashary A, Moses A, Costin C Eur J Epidemiol. 1988; 4(3):322-5.
PMID: 3181383 DOI: 10.1007/BF00148918.
References
1.
Obata H, Hayashi N, Motoike Y, Hisamitsu T, Okuda H, Kobayashi S
. A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection. Int J Cancer. 1980; 25(6):741-7.
DOI: 10.1002/ijc.2910250609.
View
2.
Barker L, Murray R
. Aquisition of hepatitis-associated antigen. Clinical features in young adults. JAMA. 1971; 216(12):1970-6.
View
3.
Nielsen J, Dietrichson O, Elling P, Christoffersen P
. Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. N Engl J Med. 1971; 285(21):1157-60.
DOI: 10.1056/NEJM197111182852101.
View
4.
SINGLETON J, Merrill D, Fitch R, Kohler P, Rettberg W
. Liver disease in Australia-antigen-positive blood-donors. Lancet. 1971; 2(7728):785-7.
DOI: 10.1016/s0140-6736(71)92740-1.
View
5.
Barker L, Murray R
. Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis--associated antigen. Am J Med Sci. 1972; 263(1):27-33.
DOI: 10.1097/00000441-197201000-00005.
View